share_log

HC Wainwright & Co. Initiates Coverage On Finch Therapeutics Group with Buy Rating, Announces Price Target of $17

HC Wainwright & Co. Initiates Coverage On Finch Therapeutics Group with Buy Rating, Announces Price Target of $17

HC Wainwright & Co.以買入評級啓動對Finch Therapeutics集團的報道,宣佈目標股價爲17美元
Benzinga Real-time News ·  2022/08/09 06:26

HC Wainwright & Co. analyst Vernon Bernardino initiates coverage on Finch Therapeutics Group (NASDAQ:FNCH) with a Buy rating and announces Price Target of $17.

HC Wainwright&Co.分析師弗農·貝爾納迪諾以買入評級啟動對芬奇治療集團(納斯達克:FNCH)的報道,並宣佈目標價為17美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論